 Saritha Ranabothu
Concepts (98)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calculi | 1 | 2018 | 5 | 0.620 |
Why?
| | Urolithiasis | 1 | 2018 | 4 | 0.620 |
Why?
| | Kidney Calculi | 1 | 2018 | 22 | 0.610 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2023 | 170 | 0.570 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 170 | 0.570 |
Why?
| | Coronavirus Infections | 1 | 2020 | 179 | 0.560 |
Why?
| | Kidney Transplantation | 3 | 2024 | 174 | 0.540 |
Why?
| | Age Determination by Skeleton | 1 | 2015 | 6 | 0.500 |
Why?
| | Bone Diseases | 1 | 2015 | 97 | 0.450 |
Why?
| | Stroke | 3 | 2021 | 479 | 0.350 |
Why?
| | Anemia, Sickle Cell | 2 | 2021 | 94 | 0.340 |
Why?
| | Nephrology | 1 | 2024 | 11 | 0.230 |
Why?
| | Lymphoproliferative Disorders | 1 | 2024 | 26 | 0.230 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 29 | 0.230 |
Why?
| | Hypothermia, Induced | 1 | 2023 | 39 | 0.210 |
Why?
| | Renal Insufficiency | 1 | 2023 | 107 | 0.200 |
Why?
| | Child | 7 | 2024 | 6837 | 0.200 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2023 | 54 | 0.200 |
Why?
| | Diastole | 1 | 2021 | 70 | 0.190 |
Why?
| | Intracranial Thrombosis | 1 | 2020 | 16 | 0.180 |
Why?
| | Anemia | 1 | 2021 | 66 | 0.180 |
Why?
| | Cerebral Infarction | 1 | 2021 | 39 | 0.180 |
Why?
| | Humans | 15 | 2024 | 49820 | 0.170 |
Why?
| | Conflict of Interest | 1 | 2020 | 25 | 0.170 |
Why?
| | Venous Thrombosis | 1 | 2020 | 89 | 0.170 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 286 | 0.160 |
Why?
| | Lupus Nephritis | 1 | 2019 | 17 | 0.160 |
Why?
| | Fabry Disease | 1 | 2019 | 9 | 0.160 |
Why?
| | Enzyme Replacement Therapy | 1 | 2019 | 17 | 0.160 |
Why?
| | Female | 8 | 2023 | 26509 | 0.160 |
Why?
| | Interferon Type I | 1 | 2019 | 24 | 0.160 |
Why?
| | Kidney Tubules | 1 | 2019 | 61 | 0.160 |
Why?
| | Ischemic Attack, Transient | 1 | 2019 | 56 | 0.160 |
Why?
| | Cardiology | 1 | 2020 | 87 | 0.160 |
Why?
| | Keratinocytes | 1 | 2019 | 90 | 0.160 |
Why?
| | Male | 7 | 2021 | 25382 | 0.160 |
Why?
| | Blood Pressure | 1 | 2021 | 517 | 0.160 |
Why?
| | Calcium Oxalate | 1 | 2018 | 8 | 0.160 |
Why?
| | Child, Preschool | 3 | 2024 | 3871 | 0.160 |
Why?
| | Uric Acid | 1 | 2018 | 21 | 0.150 |
Why?
| | Lithotripsy | 1 | 2018 | 11 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2019 | 110 | 0.150 |
Why?
| | Thrombolytic Therapy | 1 | 2019 | 110 | 0.150 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 125 | 0.150 |
Why?
| | Prevalence | 1 | 2020 | 951 | 0.140 |
Why?
| | Transcriptome | 1 | 2019 | 312 | 0.140 |
Why?
| | Disease Management | 1 | 2018 | 175 | 0.140 |
Why?
| | Infant | 2 | 2023 | 3564 | 0.130 |
Why?
| | Hypertension | 1 | 2021 | 531 | 0.130 |
Why?
| | Pandemics | 1 | 2020 | 566 | 0.130 |
Why?
| | Pediatrics | 1 | 2018 | 274 | 0.120 |
Why?
| | Adolescent | 3 | 2021 | 6391 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2018 | 953 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1029 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2020 | 5160 | 0.110 |
Why?
| | Prognosis | 1 | 2018 | 1948 | 0.110 |
Why?
| | United States | 2 | 2020 | 4870 | 0.100 |
Why?
| | Telemedicine | 1 | 2019 | 465 | 0.100 |
Why?
| | Prospective Studies | 2 | 2022 | 2341 | 0.060 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 39 | 0.060 |
Why?
| | Time Factors | 2 | 2021 | 2883 | 0.060 |
Why?
| | Viral Load | 1 | 2024 | 76 | 0.060 |
Why?
| | DNA, Viral | 1 | 2024 | 133 | 0.060 |
Why?
| | Renal Replacement Therapy | 1 | 2023 | 28 | 0.050 |
Why?
| | Oximetry | 1 | 2023 | 65 | 0.050 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2021 | 35 | 0.050 |
Why?
| | Caregivers | 1 | 2023 | 212 | 0.050 |
Why?
| | Health Care Sector | 1 | 2020 | 15 | 0.040 |
Why?
| | Drug Industry | 1 | 2020 | 38 | 0.040 |
Why?
| | Administration, Oral | 1 | 2020 | 432 | 0.040 |
Why?
| | alpha-Galactosidase | 1 | 2019 | 9 | 0.040 |
Why?
| | Hemorrhage | 1 | 2020 | 194 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 83 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2019 | 69 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 62 | 0.040 |
Why?
| | Fibrosis | 1 | 2019 | 178 | 0.040 |
Why?
| | Heart | 1 | 2021 | 330 | 0.040 |
Why?
| | Kidney | 1 | 2023 | 672 | 0.040 |
Why?
| | Incidence | 1 | 2021 | 981 | 0.040 |
Why?
| | Computational Biology | 1 | 2019 | 213 | 0.040 |
Why?
| | Brain Ischemia | 1 | 2019 | 157 | 0.040 |
Why?
| | Protein Binding | 1 | 2019 | 651 | 0.040 |
Why?
| | Biopsy | 1 | 2019 | 591 | 0.040 |
Why?
| | Quality of Life | 1 | 2023 | 837 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2022 | 2170 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2019 | 285 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 660 | 0.030 |
Why?
| | Skin | 1 | 2019 | 412 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 2469 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 1568 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2023 | 2723 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 487 | 0.030 |
Why?
| | Middle Aged | 2 | 2019 | 12253 | 0.030 |
Why?
| | Arkansas | 1 | 2019 | 1982 | 0.030 |
Why?
| | Signal Transduction | 1 | 2019 | 1602 | 0.030 |
Why?
| | Young Adult | 1 | 2021 | 4012 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2019 | 6105 | 0.020 |
Why?
| | Aged | 1 | 2019 | 9427 | 0.020 |
Why?
|
|
Ranabothu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|